Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Morein

Showing results (151-160 of 163) with videos related to

Pageof 17
Sort By:
The Journal of Infectious Diseases|May 21, 1998
Heterotypic protection against influenza by immunostimulating complexes is associated with the induction of cross-reactive cytotoxic T lymphocytesS Sambhara, S Woods, R Arpino, et al.
Revue Scientifique Et Technique (International Office of Epizootics)|December 1, 1996
Contagious bovine pleuropneumonia vaccines: the current situation and the need for improvementJ J Tulasne, J K Litamoi, B Morein, et al.
Journal of Clinical Microbiology|August 1, 1997
Phylogenetic placement and characterization of a new alpha-2 proteobacterium isolated from a patient with sepsisG Blomqvist, L Wesslén, C Påhlson, et al.
Vaccine|November 19, 1997
A recombinant prime, peptide boost vaccination strategy can focus the immune response on to more than one epitope even though these may not be immunodominant in the complex immunogenD Davis, B Morein, L Akerblom, et al.
Journal of Medical Primatology|February 1, 1992
Comparison of protection from homologous cell-free vs cell-associated SIV challenge afforded by inactivated whole SIV vaccinesJ L Heeney, P de Vries, R Dubbes, et al.
Clinical and Experimental Immunology|March 11, 2004
Antibody responses to human rotavirus (HRV) in gnotobiotic pigs following a new prime/boost vaccine strategy using oral attenuated HRV priming and intranasal VP2/6 rotavirus-like particle (VLP) boosting with ISCOMA M González, T V Nguyen, M S P Azevedo, et al.
Journal of Medical Primatology|September 25, 1998
The role of type-1 and type-2 T-helper immune responses in HIV-1 vaccine protectionJ L Heeney, M E van Gils, P van der Meide, et al.
Vaccine|October 1, 1989
Immune response to immunostimulatory complexes (ISCOMs) prepared from human immunodeficiency virus type 1 (HIV-1) or the HIV-1 external envelope glycoprotein (gp120)S W Pyle, B Morein, J W Bess, et al.
Journal of Medical Primatology|December 11, 1999
Efforts to broaden HIV-1-specific immunity by boosting with heterologous peptides or envelope protein and the influence of prior exposure to virusE J Verschoor, D Davis, M van Gils, et al.
Vaccine|August 19, 2003
Protection and antibody responses to oral priming by attenuated human rotavirus followed by oral boosting with 2/6-rotavirus-like particles with immunostimulating complexes in gnotobiotic pigsT V Nguyen, C Iosef, K Jeong, et al.
Pageof 17

Showing results (151-160 of 163) with videos related to

Sort By:
Pageof 17
The Journal of Infectious Diseases|May 21, 1998
Heterotypic protection against influenza by immunostimulating complexes is associated with the induction of cross-reactive cytotoxic T lymphocytesS Sambhara, S Woods, R Arpino, et al.
Revue Scientifique Et Technique (International Office of Epizootics)|December 1, 1996
Contagious bovine pleuropneumonia vaccines: the current situation and the need for improvementJ J Tulasne, J K Litamoi, B Morein, et al.
Journal of Clinical Microbiology|August 1, 1997
Phylogenetic placement and characterization of a new alpha-2 proteobacterium isolated from a patient with sepsisG Blomqvist, L Wesslén, C Påhlson, et al.
Vaccine|November 19, 1997
A recombinant prime, peptide boost vaccination strategy can focus the immune response on to more than one epitope even though these may not be immunodominant in the complex immunogenD Davis, B Morein, L Akerblom, et al.
Journal of Medical Primatology|February 1, 1992
Comparison of protection from homologous cell-free vs cell-associated SIV challenge afforded by inactivated whole SIV vaccinesJ L Heeney, P de Vries, R Dubbes, et al.
Clinical and Experimental Immunology|March 11, 2004
Antibody responses to human rotavirus (HRV) in gnotobiotic pigs following a new prime/boost vaccine strategy using oral attenuated HRV priming and intranasal VP2/6 rotavirus-like particle (VLP) boosting with ISCOMA M González, T V Nguyen, M S P Azevedo, et al.
Journal of Medical Primatology|September 25, 1998
The role of type-1 and type-2 T-helper immune responses in HIV-1 vaccine protectionJ L Heeney, M E van Gils, P van der Meide, et al.
Vaccine|October 1, 1989
Immune response to immunostimulatory complexes (ISCOMs) prepared from human immunodeficiency virus type 1 (HIV-1) or the HIV-1 external envelope glycoprotein (gp120)S W Pyle, B Morein, J W Bess, et al.
Journal of Medical Primatology|December 11, 1999
Efforts to broaden HIV-1-specific immunity by boosting with heterologous peptides or envelope protein and the influence of prior exposure to virusE J Verschoor, D Davis, M van Gils, et al.
Vaccine|August 19, 2003
Protection and antibody responses to oral priming by attenuated human rotavirus followed by oral boosting with 2/6-rotavirus-like particles with immunostimulating complexes in gnotobiotic pigsT V Nguyen, C Iosef, K Jeong, et al.
Pageof 17